Patent US4146647A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4146647A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted phenyl-amidines

Assignee: Cephalon France SAS
•
Filing: 1977-01-25
•
Granted: 1979-03-27
•
Expires: 1997-01-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides compounds of the formula: ##STR1## in which A is CH 2 , CHOH, CH 2 O, CH 2 S, CH 2 NH, OCH 2 , SCH 2 , NH, NHCH 2 , NHCOCH 2 or CH 2 NHCH 2 , X 1 is H, halogen, C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy, X 2 is halogen, C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy, Z is 2-pyrimidinyl or C(═NR 1 )NHR 2 (where R 1 is H and R 2 is H, OH or CH 2 CO 2 Et, or R 1 and R 2 together form CH 2 CH 2 , CH 2 CH 2 CH 2 or N═N), and their addition salts. The compounds of formula I and their salts are useful in therapy as hypotensive agents.

Inventors

  • 👤 Louis Lafon

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 05:32
CPC Classifications
C; C07; C07D; C07D257/00; C07D257/02; C07D257/04; A; A61; A61K; A61K31/00; A61K31/13; A61K31/155; A61P; A61P25/00; A61P25/26; A61P9/00; A61P9/12; C07C; C07C255/00; C07C257/00; C07C257/10; C07D233/00; C07D233/04; C07D233/20; C07D233/22; C07D233/28; C07D233/30; C07D233/42; C07D239/00; C07D239/02; C07D239/06; C07D239/24; C07D239/26; C07D239/28; C07D239/32; C07D239/42

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 68 words
A phenyl-amidoxime of the formula: ##STR33## wherein A represents --CH 2 --, --CHOH--, --CH 2 O--, --CH 2 S--, --OCH 2 --, --SCH 2 --, --NHCH 2 --, --NHCOCH 2 --, or --CH 2 NHCH 2 --, X 1 represents hydrogen, halogen, C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy, X 2 represents halogen, C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy.
Claim 2
Dependent Claim 68 words
A phenyl-amidoxime of the formula: ##STR33## wherein A represents --CH 2 --, --CHOH--, --CH 2 O--, --CH 2 S--, --OCH 2 --, --SCH 2 --, --NHCH 2 --, --NHCOCH 2 --, or --CH 2 NHCH 2 --, X 1 represents hydrogen, halogen, C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy, X 2 represents halogen, C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy.
Claim 3
Dependent Claim 43 words
A phenyl-amidine according to claim 1 in which X 1 is hydrogen, Cl, F, CH 3 , OCH 3 , or OC 2 H 5 and X 2 is Cl, F, CH 3 , OCH 3 , or OC 2 H 5 .
Claim 4
Dependent Claim 13 words
A phenyl-amidine derivative according to claim 1, wherein A is --NHCH 2 --.
Claim 5
Dependent Claim 1 words
(3,4-Dichlorophenyl)-acetamidoxime.
Claim 6
Dependent Claim 1 words
(3,4-Dichlorophenyl)-acetamidoxime.
Claim 7
Dependent Claim 1 words
(2,6-Dichloroformanilido)-acetamidoxime.
Claim 8
Dependent Claim 1 words
(2,6-Dichloroformanilido)-acetamidoxime.
Claim 9
Dependent Claim 1 words
(2,6-Dichlorobenzylamino)-acetamidoxime.
Claim 10
Dependent Claim 1 words
(2,6-Dichlorobenzylamino)-acetamidoxime.
Claim 11
Dependent Claim 1 words
(3,5-Diethoxyphenoxy)-acetamidoxime.
Claim 12
Dependent Claim 1 words
(3,5-Diethoxyphenoxy)-acetamidoxime.
Claim 13
Dependent Claim 1 words
(3,4-Dichloroanilino)-acetamidoxime.
Claim 14
Dependent Claim 1 words
(3,4-Dichloroanilino)-acetamidoxime.
Claim 15
Dependent Claim 1 words
(4-Chloroanilino)-acetamidoxime.
Claim 16
Dependent Claim 1 words
(4-Chloroanilino)-acetamidoxime.
Claim 17
Dependent Claim 1 words
(3-Fluoroanilino)-acetamidoxime.
Claim 18
Dependent Claim 1 words
(3-Fluoroanilino)-acetamidoxime.
Claim 19
Dependent Claim 19 words
A therapeutic composition, comprising at least one compound according to claim 1 in association with a physiologically acceptable excipient.

References Cited (Backward Citations)

US3234255A Cited
US3115525A Cited
US3394181A Cited
US3855249A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-03-26 1982-09-25 1983-03-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-03-26 1986-09-25 1987-03-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-03-26 1990-09-25 1991-03-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag